Short Interest in Bavarian Nordic A/S (OTCMKTS:BVNRY) Grows By 55.9%

Bavarian Nordic A/S (OTCMKTS:BVNRY) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 5,300 shares, a growth of 55.9% from the January 31st total of 3,400 shares. Based on an average trading volume of 24,500 shares, the short-interest ratio is currently 0.2 days.

Bavarian Nordic A/S Stock Performance

Bavarian Nordic A/S stock opened at $7.68 on Tuesday. The stock has a 50-day simple moving average of $8.58 and a 200 day simple moving average of $9.98. Bavarian Nordic A/S has a 52 week low of $6.86 and a 52 week high of $14.60. The stock has a market capitalization of $1.82 billion, a P/E ratio of 11.13 and a beta of 1.68.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.